ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Spybiotech Limited

Spybiotech Limited is an active company incorporated on 2 March 2017 with the registered office located in Oxford, Oxfordshire. Spybiotech Limited was registered 8 years ago.
Status
Active
Active since incorporation
Company No
10649320
Private limited company
Age
8 years
Incorporated 2 March 2017
Size
Unreported
Confirmation
Submitted
Dated 1 March 2025 (8 months ago)
Next confirmation dated 1 March 2026
Due by 15 March 2026 (4 months remaining)
Last change occurred 7 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Group
Next accounts for period 31 December 2024
Due by 31 December 2025 (1 month remaining)
Address
7600 The Quorum, Alec Issigonis Way
Oxford Business Park North
Oxford
OX4 2JZ
United Kingdom
Same address for the past 7 years
Telephone
01865 582088
Email
Unreported
People
Officers
7
Shareholders
19
Controllers (PSC)
1
Director • Chief Executive Officer • American • Lives in United States • Born in Jun 1956
Director • Associate Professor • British • Lives in England • Born in Jul 1983
Director • Senior Partner Life Sciences • French • Lives in UK • Born in Aug 1966
Director • American • Lives in United States • Born in Sep 1973
Director • Senior Executive In The Biotech Industry • American • Lives in United States • Born in Sep 1959
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Osler Diagnostics Limited
Andre Crawford-Brunt is a mutual person.
Active
Wild Bioscience Ltd
Andre Crawford-Brunt is a mutual person.
Active
Braavos Investment Advisers LLP
Andre Crawford-Brunt is a mutual person.
Active
Brands
SpyBiotech
SpyBiotech is a clinical stage company that uses protein superglue technology to develop vaccines against infectious diseases and cancer.
Financials
Net Assets, Total Assets & Total Liabilities (2018–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
£12.17M
Decreased by £4.23M (-26%)
Turnover
Unreported
Same as previous period
Employees
17
Increased by 2 (+13%)
Total Assets
£14.45M
Decreased by £4.09M (-22%)
Total Liabilities
-£3.67M
Increased by £1.1M (+43%)
Net Assets
£10.78M
Decreased by £5.2M (-33%)
Debt Ratio (%)
25%
Increased by 11.55% (+84%)
Latest Activity
Mr Stuart Chaffee Appointed
3 Months Ago on 31 Jul 2025
Daniel Menichella Resigned
3 Months Ago on 31 Jul 2025
Oxford Science Enterprises Plc (PSC) Details Changed
5 Months Ago on 21 May 2025
Confirmation Submitted
7 Months Ago on 14 Mar 2025
Group Accounts Submitted
1 Year 1 Month Ago on 16 Sep 2024
Confirmation Submitted
1 Year 7 Months Ago on 13 Mar 2024
Group Accounts Submitted
2 Years Ago on 25 Oct 2023
Accounting Period Shortened
2 Years 5 Months Ago on 11 May 2023
Confirmation Submitted
2 Years 7 Months Ago on 10 Mar 2023
Mr Edward James Gray Appointed
2 Years 9 Months Ago on 2 Feb 2023
Get Credit Report
Discover Spybiotech Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 10 September 2025
Submitted on 18 Sep 2025
Appointment of Mr Stuart Chaffee as a director on 31 July 2025
Submitted on 26 Aug 2025
Termination of appointment of Daniel Menichella as a director on 31 July 2025
Submitted on 6 Aug 2025
Resolutions
Submitted on 15 Jul 2025
Change of details for Oxford Science Enterprises Plc as a person with significant control on 21 May 2025
Submitted on 4 Jun 2025
Second filing of Confirmation Statement dated 1 March 2024
Submitted on 17 Mar 2025
Confirmation statement made on 1 March 2025 with updates
Submitted on 14 Mar 2025
Statement of capital following an allotment of shares on 19 November 2024
Submitted on 20 Nov 2024
Group of companies' accounts made up to 31 December 2023
Submitted on 16 Sep 2024
Statement of capital following an allotment of shares on 26 June 2024
Submitted on 3 Jul 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year